Novel Hep C Vaccine in Phase 1 Trial | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Fast-Track Given to Hepatitis C Drug ACH-1625

Back to News Homepage
Next

Liver Cancer More Likely with Hep C and Fatty Liver

Novel Hep C Vaccine in Phase 1 Trial

The Editors at Hepatitis Central
January 9, 2012

Print this page

By targeting the inside of a Hepatitis C viral cell for a greater T-cell response, Oxford researchers are one step closer to a vaccine for preventing Hepatitis C infection.

New vaccine for hepatitis C underway

A new vaccine for hepatitis C had been developed by a team of experts recently. The first clinical trial for testing the efficacy of the vaccine has yielded positive results, as reported by Oxford University professionals.

The vaccine was developed by a collaboration of scientists from the Oxford University, the University of Birmingham and an Italian biotech company. This team aimed to use a new avenue to instigate a distinct arm of the immune mechanism than the one used in initial studies. This injection is formulated to enable T cell responsiveness to the more consistent areas of the hepatitis C virus, instead of striking the outer coat of the virus which keeps varying persistently.

Continue reading this entire article:

http://www.healthjockey.com/2012/01/05/new-vaccine-for-hepatitis-c-underway/#

No Comments - be the first!
Share
Share
Previous

Fast-Track Given to Hepatitis C Drug ACH-1625

Back to News Homepage
Next

Liver Cancer More Likely with Hep C and Fatty Liver

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.